RxDoctor Payments Data

In Kwon Park, MD

Internal Medicine · Lakewood, WANPI 1255588679

Payments from drug & device makers

$1,911in general payments, 2019–2025

Across 89 payments — averaging $21.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$414
  • Phathom Pharmaceuticals, Inc.$294
  • Lilly USA, LLC$234
  • Boehringer Ingelheim$167
  • AbbVie$117
  • Novo Nordisk$109
  • plus $576 from 11 others

What the payments were for

  • Food & beverage$1,89299%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,911 in reported general payments places this provider in the 90th percentile of 2,038 internal medicine providers in Washington.

See all internal medicine providers in Washington

Medicare billing

Part B allowed, 2024
$45,454
Medicare patients
115
Services billed
681

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase241$477,675
JardianceEmpagliflozin340$371,688
OzempicSemaglutide83$85,007
EliquisApixaban60$59,824
JanuviaSitagliptin Phosphate70$56,609
FarxigaDapagliflozin Propanediol46$55,200
LinzessLinaclotide80$50,736
XareltoRivaroxaban45$49,658
VascepaIcosapent Ethyl88$46,356
RestasisCyclosporine56$44,133
TrulicityDulaglutide23$34,067
Lidocaine222$28,574
RybelsusSemaglutide12$26,955
ZenpepLipase/Protease/Amylase12$26,623
ProliaDenosumab13$22,618

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess, Restasis$117$572,543377 claims
Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr$167$401,875370 claims
Novo NordiskOzempic, Rybelsus$109$111,96195 claims
MerckJanuvia, Janumet Xr$16$71,32590 claims
AstraZenecaFarxiga, Symbicort, Nexium$93$64,94379 claims
Johnson & JohnsonXarelto$64$49,65845 claims
Lilly USA, LLCTrulicity$234$34,06723 claims
Aimmune Therapeutics, Inc.Zenpep$23$26,62312 claims
AmgenProlia$414$22,61813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,038 internal medicine providers in Washington.

Other internal medicine in Lakewood

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →